This company seems to have been delisted
Reason: filed for bankruptcy
Last recorded trade on: June 14, 2024
Source: https://www.biopharmadive.com/news/acorda-bankruptcy-asset-sale-merz-stalking-horse/712010/
Reason: filed for bankruptcy
Last recorded trade on: June 14, 2024
Source: https://www.biopharmadive.com/news/acorda-bankruptcy-asset-sale-merz-stalking-horse/712010/
Acorda Therapeutics
ACOR
0,57 €
Share price
0.00%
Change (1 day)
-95.92%
Change (1 year)
Categories
Acorda Therapeutics (ACOR) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : €0.23 Billion
According to Acorda Therapeutics 's latest financial reports the company's total liabilities are €0.23 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Acorda Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | €0.28 B | 4.76% |
| 2021-12-31 | €0.26 B | -16.26% |
| 2020-12-31 | €0.32 B | -26.47% |
| 2019-12-31 | €0.43 B | -27.4% |
| 2018-12-31 | €0.60 B | 6.38% |
| 2017-12-31 | €0.56 B | -12.35% |
| 2016-12-31 | €0.64 B | 38.69% |
| 2015-12-31 | €0.46 B | 7.73% |
| 2014-12-31 | €0.43 B | 257.32% |
| 2013-12-31 | €0.12 B | -10.96% |
| 2012-12-31 | €0.13 B | 1.07% |
| 2011-12-31 | €0.13 B | -6.47% |
| 2010-12-31 | €0.14 B | 12.86% |
| 2009-12-31 | €0.12 B | 139.06% |
| 2008-12-31 | €53.17 M | 21.56% |
| 2007-12-31 | €43.74 M | -12.14% |
| 2006-12-31 | €49.79 M | -60.8% |
| 2005-12-31 | €0.12 B | 88.18% |
| 2004-12-31 | €67.49 M | 84.36% |
| 2003-12-31 | €36.6 M | |
| 2003-06-30 | €25.77 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | €0.75 B | 224.17% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | €1.17 B | 406.29% | 🇺🇸 USA |
 Affimed
AFMD | €21.94 M | -90.52% | 🇩🇪 Germany |
 Sarepta Therapeutics
SRPT | €2.01 B | 768.78% | 🇺🇸 USA |